Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency (RF) Ablation Prospective Outcomes Study

NCT04673032 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04673032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency (RF) Ablation Prospective Outcomes Study
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
December 22, 2020
Completion date
February 7, 2025
Enrollment
298 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pain, chronic